Arkolith/Insider Trading/OKYO/Form 4/A

Cerrone Gabriele M

Non-Executive Chairman, Director, 10% OwnerOKYO Pharma Ltd (OKYO) · full profile →Form 4/A · filed May 18, 2022
Net Buying
Open-Market Buys
$97K
Open-Market Sells
$0
Net Open-Market Flow
$97K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 17, 2022Buy(P)25K$3.87$97K25K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001493152-22-014299) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML